![The Novel Endothelin Receptor Antagonist, Macitentan, Improved Right Ventricular Function and Normalized Glucose Uptake in a Sugen5416/hypoxia Rat Model of Severe Pulmonary Artery Hypertension]()
The Novel Endothelin Receptor Antagonist, Macitentan, Improved Right Ventricular Function and Normalized Glucose Uptake in a Sugen5416/hypoxia Rat Model of Severe Pulmonary Artery HypertensionDrozd, Katarzyna; Deng, Yupu; Jiang, Baohua; Lockwood, Julia; Thorn, Stephanie; Stewart, Duncan J.; Beanlands, Rob; deKemp, Rob; DaSilva, Jean; Mielniczuk, Lisa M. · Journal of Cardiac Failure · 2014